Fluoxetine reduces intravenous cocaine self-administration in rats

https://doi.org/10.1016/0091-3057(90)90232-7Get rights and content

Abstract

Rats self-administered intravenously delivered cocaine (0.2 mg/kg) under a fixed-ratio (FR) 4 schedule during 24-hr sessions. Water was freely available from both a drinkometer and a standard water bottle. After behavior had stabilized,the rats were injected with fluoxetine HCl at 10:00 a.m. and 4:00 p.m. for 5 consecutive days. Three groups of 5 rats each received a different dose of fluoxetine (2.5, 5 or 10 mg/kg) via the IV cannula. In three other groups of rats a glucose and saccharin solution (G+S) was substituted for water in the automatic drinking device and saline was substituted for cocaine. These three groups of rats received the same fluoxetine doses as the cocaine self-injecting groups. In two additional groups of 5 rats each, the cocaine dose was changed to 0.1 or 0.4 mg/kg, and 5 mg/kg fluoxetine injections were given. The two higher doses of fluoxetine (5 and 10 mg/kg) reduced cocaine infusions (0.2 mg/kg) by at least 50 percent on all 5 days of treatment, and cocaine infusions returned to baseline levels within 48 hr after fluoxetine treatments were terminated. Behavior maintained by the G+S solution was also reduced by the two higher fluoxetine doses; however, this reduction did not reliably occur until the last two days of fluoxetine administration. The G+S intakes returned to baseline levels within 24 hr after fluoxetine treatment. Fluoxetine also reduced cocaine infusions in the group of rats that received the lower unit dose of cocaine (0.1 mg/kg); however, it had almost no effect on behavior maintained by a higher cocaine dose (0.4 mg/kg). Food and water intake, responding on an inactive lever, and the number of saline infusions were not reliably altered by the fluoxetine treatments. These results suggest that fluoxetine alters the reinforcing effects of cocaine as well as a nondrug substance.

References (40)

  • J.R. Weeks

    Long term intravenous infusion

  • D.S.L. Yu et al.

    Fluoxetine-induced attenuation of amphetamine self-administration in rats

    Life Sci.

    (1986)
  • J.E. Zabik et al.

    5-Hydroxytryptophan-induced conditioned taste aversion to ethanol in the rat

    Pharmacol. Biochem. Behav.

    (1983)
  • D.M. Atrens et al.

    Specific inhibition of hypothalamic self-stimulation by selective re-uptake blockers of either 5-hydroxytryptamine or noradrenaline

    Psychopharmacology (Berlin)

    (1977)
  • M.E. Carroll et al.

    Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation

    J. Pharmacol. Exp. Ther.

    (1981)
  • M.E. Carroll et al.

    A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior

    Psychopharmacology (Berlin)

    (1989)
  • M.E. Carroll et al.

    Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation

    J. Exp. Pharmacol. Ther.

    (1986)
  • P. Cazala

    Effects of Lilly 110140 (Fluxetine) on self-stimulation behavior in the dorsal and ventral regions of the lateral hypothalamus in the mouse

    Psychopharmacology (Berlin)

    (1980)
  • E. Friedman et al.

    Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain

    Br. J. Pharmacol.

    (1975)
  • F.H. Gawin

    Chronic neuropharmacology of cocaine: Progress in pharmacotherapy

    J. Clin. Psychol.

    (1988)
  • Cited by (228)

    • Serotonin neurobiology in cocaine use disorder

      2020, Handbook of Behavioral Neuroscience
    • Do dorsal raphe 5-HT neurons encode “beneficialness”?

      2016, Neurobiology of Learning and Memory
      Citation Excerpt :

      Early pharmacological studies suggest that 5-HT encodes punishment signals by opposing dopamine actions (Daw et al., 2002; Di Giovanni, Esposito, & Di Matteo, 2010; Hashimoto, Inoue, & Koyama, 1996; Macoveanu, 2014; Tye, Everitt, & Iversen, 1977). Indeed, increasing central 5-HT levels reduces the consumption of natural rewarding stimuli (Fletcher & Korth, 1999; Fletcher, Korth, & Chambers, 1999; Sanders, Hussain, Hen, & Zhuang, 2007) and addictive drug (Carroll, Lac, Asencio, & Kragh, 1990; Leccese & Lyness, 1984; McGregor, Lacosta, & Roberts, 1993; Peltier & Schenk, 1993; Smith, Dianna, Smith, Leccese, & Lyness, 1986). However, the reward antagonism theory does not fit well with our observations that natural rewards but not aversive stimuli excite DRN 5-HT neurons.

    View all citing articles on Scopus
    View full text